Financial Statements · Financial Reporting
AstraZeneca Eesti OÜ
Official identifier 11733875Record date 31 Dec 2025
EstoniaReport
- Legal formThe legal or organisational form recorded by the Estonian Business Register. Learn more
- OÜ
- Report status
- Registered
Dates
- Reporting year
- 2025
- Period start
- 1 Jan 2025
- Submitted date
- 19 Jun 2026
Report
- Consolidated
- No
- Audited
- Yes
Financial metrics
| Statement | Metric | Value |
|---|---|---|
| Balance sheet | Assets | 5,494,103 |
| Balance sheet | Cash and cash equivalents | 3,452,433 |
| Balance sheet | Current assets | 5,305,324 |
| Balance sheet | Current liabilities | 1,775,753 |
| Balance sheet | Equity | 3,718,350 |
| Balance sheet | Share capital at nominal value | 690,246 |
| Balance sheet | Non-current assets | 188,779 |
| Balance sheet | Retained earnings (loss) from previous periods | 2,565,563 |
| Income statement scheme 1 | Depreciation and impairment of non-current assets | -19,532 |
| Income statement scheme 1 | Labour costs | -4,615,798 |
| Income statement scheme 1 | Revenue | 6,969,720 |
| Income statement scheme 1 | Annual period profit / loss | 393,516 |
| Income statement scheme 1 | Operating profit (loss) | 388,706 |
| Income statement scheme 1 | Profit (loss) before income tax | 393,516 |
| Profit distribution proposal | Retained earnings (loss) from previous periods | 2,565,563 |
| Note: Labour costs | Employees | 44 |
| Note: Labour costs | Labour costs | 4,615,798 |
Linked company
Company: AstraZeneca Eesti OÜ